VKORC1 Diplotype-Derived Dosing Model to Explain Variability in Warfarin Dose Requirements in Asian Patients

スポンサーリンク

概要

論文の詳細を見る
2009-08-25

著者

SANDANARAJ Edwin
Laboratory of Clinical Pharmacology, Division of Medical Sciences, Humphrey Oei Institute of Cancer
LAL Suman
Laboratory of Clinical Pharmacology, Division of Medical Sciences, Humphrey Oei Institute of Cancer
CHEUNG Yin
Department of Biostatistics, Clinical Trials & Epidemiology Research Unit
XIANG Xiaoqiang
Laboratory of Clinical Pharmacology, Division of Medical Sciences, Humphrey Oei Institute of Cancer
KONG Ming
Department of Pharmacy, Singapore General Hospital
LEE Lai
Department of Haematology, Singapore General Hospital
OOI London
Department of Surgical Oncology, Humphrey Oei Institute of Cancer Research, National Cancer Centre
CHOWBAY Balram
Laboratory of Clinical Pharmacology, Division of Medical Sciences, Humphrey Oei Institute of Cancer
Lee Lai
Department Of Haematology Singapore General Hospital
Lal Suman
Laboratory Of Clinical Pharmacology Division Of Medical Sciences Humphrey Oei Institute Of Cancer Re
Kong Ming
Department Of Pharmacy Singapore General Hospital
Cheung Yin
Department Of Biostatistics Clinical Trials & Epidemiology Research Unit
Ooi London
Department Of Surgical Oncology Humphrey Oei Institute Of Cancer Research National Cancer Centre
Ooi London
Department Of Surgery Singapore General Hospital
Chowbay Balram
Laboratory Of Clinical Pharmacology Division Of Medical Sciences Humphrey Oei Institute Of Cancer Re
Sandanaraj Edwin
Laboratory Of Clinical Pharmacology Division Of Medical Sciences Humphrey Oei Institute Of Cancer Re
Xiang Xiaoqiang
Laboratory Of Clinical Pharmacology Division Of Medical Sciences Humphrey Oei Institute Of Cancer Re
Chowbay Balram
Laboratory Of Clinical Pharmacology Division Of Medical Sciences Humphrey Oei Institute Of Cancer Re

関連論文

スポンサーリンク